Pehar, M, Ristaino, P, Budd, A, et al. Application of the National Healthcare Safety Network (NHSN) Central Line Associated Bloodstream Infection (CLA-BSI) Definition to Oncology Patients: Impact in the Trenches, 2010. Presented at the International Conference on Healthcare-Associated Infections, March 18–22, 2010. Abstract #660.
Fraser, TG, Gordon, SM. CLABSI rates in immunocompromised patients: a valuable patient centered outcome?
Clin Infect Dis
Steinberg, JP, Robichaux, C, Tejedor, SC, Reyes, MD, Jacob, JT. Distribution of pathogens in central line-associated bloodstream infections among patients with and without neutropenia following chemotherapy: evidence for a proposed modification to the current surveillance definition. Infect Control Hosp Epidemiol
Sexton, DJ, Chen, LF, Anderson, DJ. Current definitions of central line-associated bloodstream infection: is the emperor wearing clothes?
Infect Control Hosp Epidemiol
Rettig, SL, Gross, KA, Ditaranto, S, et al. Central line-associated bloodstream infections (CLABSI) in oncology patients: the impact of mucositis on CLABSI rates, 2011. Presented at the SHEA Annual Scientific Meeting, April 1–4, 2011, Dallas, Texas. Abstract #232.
Digiorgio, MJ, Fatica, C, Oden, M, et al. Development of a modified surveillance definition of central line-associated bloodstream infections for patients with hematologic malignancies. Infect Control Hosp Epidemiol
Worth, LJ, Slavin, MA, Brown, GV, Black, J. Catheter-related bloodstream infections in hematology: time for standardized surveillance?
Tancrede, CH, Andremont, AO. Bacterial translocation and gram-negative bacteremia in patients with hematological malignancies. J Infect Dis
Blijlevens, NM, Donnelly, JP, De Pauw, BE. Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview. Bone Marrow Transplant
See, I, Iwamoto, M, Allen-Bridson, K, Horan, T, Magill, SS, Thompson, ND. Mucosal barrier injury laboratory-confirmed bloodstream infection: results from a field test of a new National Healthcare Safety Network definition. Infect Control Hosp Epidemiol
13. Bloodstream Infection Event (Central Line-Associated Bloodstream Infection and Non-central line-associated Bloodstream Infection). The Centers for Disease Control and Prevention Web site. http://www.cdc.gov/nhsn/PDFs/pscManual/4PSC_CLABScurrent.pdf. Published January 2015. Accessed February 3, 2015.
14. National Action Plan to Prevent Health Care-Assocation Infections: Road Map to Elimination. Office of Disease Prevention and Health Promotion, Office of the Assistant Secretary for Health, Office of the Secretary, U.S. Department of Health and Human Services Web site. http://www.health.gov/hai/prevent_hai.asp. Accessed March 23, 2015.
Gaur, AH, Bundy, DG, Gao, C, et al. Surveillance of hospital-acquired central line-associated bloodstream infections in pediatric hematology-oncology patients: lessons learned, challenges ahead. Infect Control Hosp Epidemiol
Freeman, JT, Elinder-Camburn, A, McClymont, C, et al. Central line-associated bloodstream infections in adult hematology patients with febrile neutropenia: an evaluation of surveillance definitions using differential time to blood culture positivity. Infect Control Hosp Epidemiol
Metzger, KE, Rucker, Y, Callaghan, M, et al. The burden of mucosal barrier injury laboratory-confirmed bloodstream infection among hematology, oncology and stem cell transplant patients. Infect Control Hosp Epidemiol
Dudeck, MA, Edwards, JR, Allen-Bridson, K, et al. National Healthcare Safety Network report, data summary for 2013, device-associated module. Am J Infect Control